CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-29 | Moin Andrew Director | Option exercise | +1,740,000 | $1.75 | $3.0M | 2,198,457 |
| 2025-09-29 | Moin Andrew Director | Option exercise · Series B Convertible Preferred Stock | −17,400 | 211,100 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Series B Convertible Preferred Stock | +228,500 | 228,500 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Warrants (right to buy) | +228,500 | 228,500 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Warrants (right to buy) | +114,250 | 114,250 | ||
| 2023-11-24 | Moin Andrew Director | Option exercise | +4,584,571 | 4,584,571 | ||
| 2023-11-24 | Moin Andrew Director | Option exercise · Series A-1 Convertible Preferred Stock | −31,269 | $1,000.00 | $31.3M | 0 |
| 2023-11-24 | Moin Andrew Director | Option exercise · Series A-2 Convertible Preferred Stock | +28,380 | $1,000.00 | $28.4M | 28,380 |
| 2023-11-13 | Moin Andrew Director | Grant or award · Series A-1 Convertible Preferred Stock | +13,269 | $1,000.00 | $13.3M | 31,269 |
| 2023-11-13 | Moin Andrew Director | Option exercise · Preferred Tranche A Warrants | −13,269 | 0 | ||
| 2023-11-13 | Moin Andrew Director | Grant or award · Series A-1 Convertible Preferred Stock | +13,269 | $1,000.00 | $13.3M | 13,269 |
| 2023-11-10 | Moin Andrew Director | Grant or award · Preferred Tranche A Warrants | +13,269 | 13,269 | ||
| 2023-11-10 | Moin Andrew Director | Grant or award · Preferred Tranche B Warrants | +8,846 | 20,846 | ||
| 2023-11-10 | Moin Andrew Director | Grant or award · Preferred Tranche C Warrants | +22,115 | 52,115 | ||
| 2023-10-23 | Moin Andrew Director | Grant or award · Series A-1 Convertible Preferred Stock | +16,269 | $1,000.00 | $16.3M | 18,000 |
| 2023-10-23 | Moin Andrew Director | Option exercise · Preferred Tranche A Warrants | −16,269 | 0 |
Page 1 of 1 · 16 trades